The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hospital Infection Therapeutics Market Research Report 2025
Synopsis
Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.
The global Hospital Infection Therapeutics market was valued at US$ 2724.5 million in 2023 and is anticipated to reach US$ 3240.4 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital Infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Infection Therapeutics.
Report Scope
The Hospital Infection Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital Infection Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Infection Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Johnson & Johnson Services
Actavis
Sanofi
Bristol Myers Squibb Company
AstraZeneca
Pfizer
Merck
GlaxoSmithkline
Cubist Pharmaceuticals
Segment by Type
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Segment by Application
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Infection Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.
The global Hospital Infection Therapeutics market was valued at US$ 2724.5 million in 2023 and is anticipated to reach US$ 3240.4 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital Infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Infection Therapeutics.
Report Scope
The Hospital Infection Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital Infection Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Infection Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Johnson & Johnson Services
Actavis
Sanofi
Bristol Myers Squibb Company
AstraZeneca
Pfizer
Merck
GlaxoSmithkline
Cubist Pharmaceuticals
Segment by Type
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Segment by Application
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Infection Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Infection Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibacterial Drugs
1.2.3 Antiviral Drugs
1.2.4 Antifungal Drugs
1.3 Market by Application
1.3.1 Global Hospital Infection Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Acquired Pneumonia
1.3.3 Surgical Site Infections
1.3.4 Urinary Tract Infection
1.3.5 Gastrointestinal Disorders
1.3.6 Bloodstream Infections
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Infection Therapeutics Market Perspective (2019-2030)
2.2 Hospital Infection Therapeutics Growth Trends by Region
2.2.1 Global Hospital Infection Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital Infection Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Hospital Infection Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Hospital Infection Therapeutics Market Dynamics
2.3.1 Hospital Infection Therapeutics Industry Trends
2.3.2 Hospital Infection Therapeutics Market Drivers
2.3.3 Hospital Infection Therapeutics Market Challenges
2.3.4 Hospital Infection Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Infection Therapeutics Players by Revenue
3.1.1 Global Top Hospital Infection Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Hospital Infection Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Hospital Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Infection Therapeutics Revenue
3.4 Global Hospital Infection Therapeutics Market Concentration Ratio
3.4.1 Global Hospital Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Infection Therapeutics Revenue in 2023
3.5 Hospital Infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Hospital Infection Therapeutics Product Solution and Service
3.7 Date of Enter into Hospital Infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Infection Therapeutics Breakdown Data by Type
4.1 Global Hospital Infection Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Hospital Infection Therapeutics Forecasted Market Size by Type (2025-2030)
5 Hospital Infection Therapeutics Breakdown Data by Application
5.1 Global Hospital Infection Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Hospital Infection Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital Infection Therapeutics Market Size (2019-2030)
6.2 North America Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital Infection Therapeutics Market Size by Country (2019-2024)
6.4 North America Hospital Infection Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital Infection Therapeutics Market Size (2019-2030)
7.2 Europe Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital Infection Therapeutics Market Size by Country (2019-2024)
7.4 Europe Hospital Infection Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Infection Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Hospital Infection Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital Infection Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital Infection Therapeutics Market Size (2019-2030)
9.2 Latin America Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital Infection Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Hospital Infection Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Infection Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Hospital Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital Infection Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Hospital Infection Therapeutics Introduction
11.1.4 Bayer Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Johnson & Johnson Services
11.2.1 Johnson & Johnson Services Company Detail
11.2.2 Johnson & Johnson Services Business Overview
11.2.3 Johnson & Johnson Services Hospital Infection Therapeutics Introduction
11.2.4 Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.2.5 Johnson & Johnson Services Recent Development
11.3 Actavis
11.3.1 Actavis Company Detail
11.3.2 Actavis Business Overview
11.3.3 Actavis Hospital Infection Therapeutics Introduction
11.3.4 Actavis Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.3.5 Actavis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Hospital Infection Therapeutics Introduction
11.4.4 Sanofi Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Bristol Myers Squibb Company
11.5.1 Bristol Myers Squibb Company Company Detail
11.5.2 Bristol Myers Squibb Company Business Overview
11.5.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Introduction
11.5.4 Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.5.5 Bristol Myers Squibb Company Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Hospital Infection Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Hospital Infection Therapeutics Introduction
11.7.4 Pfizer Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Hospital Infection Therapeutics Introduction
11.8.4 Merck Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.8.5 Merck Recent Development
11.9 GlaxoSmithkline
11.9.1 GlaxoSmithkline Company Detail
11.9.2 GlaxoSmithkline Business Overview
11.9.3 GlaxoSmithkline Hospital Infection Therapeutics Introduction
11.9.4 GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.9.5 GlaxoSmithkline Recent Development
11.10 Cubist Pharmaceuticals
11.10.1 Cubist Pharmaceuticals Company Detail
11.10.2 Cubist Pharmaceuticals Business Overview
11.10.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Introduction
11.10.4 Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2019-2024)
11.10.5 Cubist Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
